|
19 Nov 2020 |
European Commission approves Supemtek (quadrivalent recombinant influenza vaccine) for the prevention of influenza in adults aged 18 years and older
|
|
19 Nov 2020 |
Orchard Therapeutics Announces FDA Clearance of IND Application for OTL-200 for Metachromatic Leukodystrophy (MLD)
|
|
19 Nov 2020 |
Bio-Path Holdings Announces First Patient Dosed in Phase 1 Clinical Trial of BP1002
|
|
19 Nov 2020 |
Durable Responses with ADP-A2M4 in Synovial Sarcoma with Confirmed Responses in 44% of Patients and Disease Control Rate of 94% Presented at CTOS
|
|
19 Nov 2020 |
PIONYR Immunotherapeutics Initiates Phase 1 Clinical Study Of PY314
|
|
19 Nov 2020 |
Acurx Announces Positive Phase 2A Clinical Trial Results for Ibezapolstat in C. difficile Infection at Prominent International Conference
|
|
19 Nov 2020 |
VBI Vaccines Announces Positive Interim Phase 1b/2a Data for Hepatitis B Immunotherapeutic in Patients with Chronic Infection
|
|
19 Nov 2020 |
Omeros Submits its Biologics License Application to U.S. FDA for Narsoplimab in HSCT-TMA
|
|
19 Nov 2020 |
Adagio Therapeutics COVID-19 Antibody Demonstrates Best-in-Class Breadth and Potency Against a Range of Coronaviruses that Pose Human Threat
|
|
19 Nov 2020 |
NorthSea Therapeutics doses first patient in Phase 1 trial of SEFA-1024 in dyslipidemia and further expands its clinical pipeline
|
|
19 Nov 2020 |
Alnylam Receives Approval for OXLUMO™ (lumasiran) in the European Union for the Treatment of Primary Hyperoxaluria Type 1 in All Age Groups
|
|
19 Nov 2020 |
VBI Vaccines Announces Positive Interim Phase 2a Data from VBI-1901 in Recurrent GBM
|
|
19 Nov 2020 |
Bristol secures £45M to advance gene therapy treatment of chronic kidney diseases
|
|
19 Nov 2020 |
Genoscience Pharma completes successful phase 1b trial evaluating GNS561, PPT-1 inhibitor, in patients with primary and secondary liver cancer
|
|
19 Nov 2020 |
Gilead Announces Investigational Long-Acting HIV-1 Capsid Inhibitor, Lenacapavir, Achieves Primary Endpoint in Phase 2/3 Study in Heavily Treatment-Experienced People Living With HIV
|
|
19 Nov 2020 |
ImmunoPrecise and Genmab Enter into a Technology Partnership Targeting Infectious Disease
|
|
19 Nov 2020 |
Milestone Pharmaceuticals Announces First Patient Enrolled in RAPID, a Pivotal Phase 3 Study of Etripamil in PSVT
|
|
19 Nov 2020 |
Lilly and Ypsomed collaborate to advance an automated insulin delivery system for people with diabetes
|
|
18 Nov 2020 |
Samsung Bioepis and Biogen Announce FDA Filing Acceptance of SB11, A Proposed Biosimilar Referencing Lucentis® (ranibizumab)
|
|
18 Nov 2020 |
Pfizer and BioNTech Conclude Phase 3 Study of COVID-19 Vaccine Candidate, Meeting All Primary Efficacy Endpoints
|
